PAM
SANA icon

Prodigy Asset Management’s Sana Biotechnology SANA Stock Holding History

Prodigy Asset Management’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$70K Hold
20,050
– – 0.02% 29
2026
Q1 		$57.7K Buy
+20,050
New +$79K 0.02% 28

Other funds holding SANA

Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
SFA
Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return
MFG
Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return
BCA
Bay Colony Advisors Concord, Massachusetts $903M AUM 33.67% 1-Year Est. Return
LI
LRI Investments Palm Beach Gardens, Florida $1.24B AUM 11.13% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

Prodigy Asset Management's SANA Position: Q2 2026 in Review

Prodigy Asset Management held its Sana Biotechnology (SANA) position steady in Q2 2026 at 20,050 shares worth $70K. The position accounts for 0.02% of the portfolio, ranked #29.

Prodigy Asset Management first reported a position in SANA in Q1 2026 and has held it in 2 quarters since. 8 funds tracked by Wall St. Rank hold SANA as of Q2 2026.

  • Prodigy Asset Management held 20,050 shares of Sana Biotechnology worth $70K as of Q2 2026.
  • Prodigy Asset Management left its Sana Biotechnology share count unchanged in Q2 2026.
  • Sana Biotechnology made up 0.02% of Prodigy Asset Management's portfolio in Q2 2026, its #29 holding.
  • Prodigy Asset Management first reported a position in Sana Biotechnology in Q1 2026 and has held it in 2 quarters since.
  • 8 funds tracked by Wall St. Rank held Sana Biotechnology as of Q2 2026.

Based on Prodigy Asset Management's 13F filing for Q2 2026, filed 7 Jul 2026.